Premium
Cellectar Biosciences Inc (CLRB)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs... Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells. Show more
Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66th Annual American Society of Hematology Meeting and Exposition Raised approximately $19.4 million with potential to...
NorthStar to provide Cellectar with non-carrier-added Ac-225 for its expanded portfolio of clinical programs FLORHAM PARK, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc...
INDIANAPOLIS and FLORHAM PARK, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SpectronRx, a leading radiopharmaceutical contract developer and manufacturer, and Cellectar Biosciences, Inc. (NASDAQ:...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1 | -6.36942675159 | 1.57 | 1.61 | 1.42 | 206382 | 1.50122745 | CS |
| 4 | -0.57 | -27.9411764706 | 2.04 | 2.2 | 1.385 | 560412 | 1.7274966 | CS |
| 12 | -0.63 | -30 | 2.1 | 2.25 | 1.385 | 330957 | 1.87884395 | CS |
| 26 | -1.51 | -50.6711409396 | 2.98 | 3.42 | 1.385 | 450998 | 2.26595897 | CS |
| 52 | -1.09 | -42.578125 | 2.56 | 4.45 | 1.385 | 832405 | 3.11770634 | CS |
| 156 | 0.85 | 137.096774194 | 0.62 | 6.7568 | 0.337 | 399894 | 2.69599319 | CS |
| 260 | -0.67 | -31.308411215 | 2.14 | 6.7568 | 0.337 | 585226 | 2.1003424 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
